Overexpression of PTGS2 has been detected in most types of cancer, including adenocarcinoma, hepatocellular carcinoma, colorectal cancer, breast cancer, pancreatic cancer, and lung cancers (Hashemi Goradel et al., 2019). Here, PTGS2 is linked to hepatocellular carcinoma.